Published in Trans Am Soc Artif Intern Organs on January 01, 1970
Experiences with a sac-type artificial heart. Can Med Assoc J (1971) 1.40
Long-term effects of the artificial heart. Ann Surg (1974) 0.82
Components of artificial hearts. Bull N Y Acad Med (1972) 0.75
Construction of plasmids carrying the cI gene of bacteriophage lambda. Proc Natl Acad Sci U S A (1976) 13.10
Plasmids of Escherichia coli as cloning vectors. Methods Enzymol (1979) 11.41
A general method for the purification of restriction enzymes. Nucleic Acids Res (1978) 7.92
Autoregulation and function of a repressor in bacteriophage lambda. Science (1976) 6.83
Physical and genetic characterization of the glnA--glnG region of the Escherichia coli chromosome. Proc Natl Acad Sci U S A (1981) 5.63
Recognition sequences of repressor and polymerase in the operators of bacteriophage lambda. Cell (1975) 4.28
Characterization of a gene, glnL, the product of which is involved in the regulation of nitrogen utilization in Escherichia coli. J Bacteriol (1982) 4.19
Maximizing gene expression on a plasmid using recombination in vitro. Cell (1978) 3.84
Clinical use of the total artificial heart. N Engl J Med (1984) 2.94
A cautionary note on the use of certain restriction endonucleases with methylated substrates. Gene (1980) 2.36
Genetic and physical studies on the replication of ColE1-type plasmids. Cold Spring Harb Symp Quant Biol (1979) 2.15
A plasmid cloning vehicle allowing a positive selection for inserted fragments. Gene (1980) 2.08
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc Natl Acad Sci U S A (2001) 1.79
Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2. Proc Natl Acad Sci U S A (2000) 1.76
First clinical application of transarterial closed-chest left ventricular (TaCLV) bypass. Trans Am Soc Artif Intern Organs (1970) 1.46
Uremic pericarditis and cardiac tamponade in chronic renal failure. Ann Intern Med (1966) 1.35
Tetracycline resistance determined by pBR322 is mediated by one polypeptide. Gene (1983) 1.27
Uremic polyneuropathy: and motor nerve conduction velocities. Trans Am Soc Artif Intern Organs (1964) 1.25
Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol Ther (2001) 1.25
Controllable alteration of cell genotype in bacterial cultures using an excision vector. Gene (1988) 1.12
Treatment of ruptured abdominal aortic aneurysm, a permanent challenge or a waste of resources? Prediction of outcome using a multi-organ-dysfunction score. Eur J Vasc Endovasc Surg (2000) 1.10
Reuse of twin-coil disposable artificial kidneys with their priming blood. JAMA (1966) 1.08
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia. Leukemia (2002) 1.07
Total replacement artificial heart and driving system with inherent regulation of cardiac output. Trans Am Soc Artif Intern Organs (1969) 1.05
Early and late failures of human cadaveric renal allografts. Arch Intern Med (1969) 1.05
Quality of life in adult patients with acute myeloid leukemia receiving intensive and prolonged chemotherapy -- a longitudinal study. Leukemia (1998) 1.05
Thyroid abnormalities in renal failure. A study of 53 patients on chronic hemodialysis. Ann Intern Med (1973) 1.02
Cultivation of Microorganisms With the Aid of Cellophane Membranes. Science (1947) 1.01
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients. Ann Oncol (2011) 0.98
The effect of allopurinol on the degree of early myocardial ischemia. Am Heart J (1980) 0.98
Elimination of some problems encountered in total replacement of the heart with an intrathoracic mechanical pump: venous return. Trans Am Soc Artif Intern Organs (1966) 0.96
Problems in calf lungs immediately after implantation of an artificial heart. Trans Am Soc Artif Intern Organs (1964) 0.96
Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3). J Am Chem Soc (2001) 0.96
Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia. Leukemia (2007) 0.95
Transarterial closed-chest left ventricular (TaCLV) bypass. Trans Am Soc Artif Intern Organs (1969) 0.93
Saving the aortic and pulmonary artery valves with total heart replacement. Trans Am Soc Artif Intern Organs (1976) 0.92
Some experiences with artificial hearts inside the chest, driven with a simple inexpensive servo-system. J Cardiovasc Surg (Torino) (1968) 0.92
Reversal of myocardial ischemia by arterialization of the coronary vein. J Thorac Cardiovasc Surg (1974) 0.91
The calmodulin-binding domain mediates the self-association of the plasma membrane Ca2+ pump. J Biol Chem (1991) 0.91
Three years' clinical experience with cadaver kidney transplantation. Transplantation (1967) 0.91
Appendix. Cloning and sequence of the gene encoding enzyme E-1 from the methionine salvage pathway of Klebsiella oxytoca. J Biol Chem (1993) 0.90
Diagnosing exertional rhabdomyolysis: a brief review and report of two cases. Mil Med (2001) 0.89
Genetic separability of the chorismate mutase and prephenate dehydrogenase components of the Escherichia coli tyrA gene product. J Bacteriol (1987) 0.89
The artificial heart: research, development or invention? Dis Chest (1969) 0.88
Endemic goiter in Greece: epidemiologic and genetic studies. J Clin Endocrinol Metab (1966) 0.88
The sad truth about hemodialysis in diabetic nephropathy. JAMA (1972) 0.88
ABO blood group incompatibility in human renal homotransplantation. Am J Clin Pathol (1969) 0.87
Retransplantation after failure of first renal homografts. Studies in 19 patients. JAMA (1967) 0.86
Use of phage immunity in molecular cloning experiments. Science (1977) 0.86
Implantation of a total artificial heart in calves under hypothermia with 10 day survival. J Thorac Cardiovasc Surg (1972) 0.85
Arterialization of the coronary vein coming from an ischemic area. Chest (1973) 0.85
Intrapulmonary artery balloon pumping. Assistance of the right ventricle. J Thorac Cardiovasc Surg (1970) 0.85
A new surgical approach to myocardial revascularization--internal mammary artery to coronary vein anastomosis. Thorax (1973) 0.84
The use of ninety-four cadaveric kidneys for transplantation--clinical experience. Br J Urol (1966) 0.84
Transapical left ventricular bypass: a method for partial or total circulatory support. Artif Organs (1978) 0.84
Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation. Clin Microbiol Infect (2007) 0.84
Transarterial closed chest left ventricular bypass for desperate heart failure. J Assoc Adv Med Instrum (1973) 0.84
Calcification of nontextured implantable blood pumps. Trans Am Soc Artif Intern Organs (1981) 0.84
Renal regulation of serum alpha-lipoproteins. Decrease of alpha-lipoproteins in the absence of renal function. N Engl J Med (1966) 0.84
Thyroid function in chronic renal failure: effects of chronic hemodialysis. Trans Am Soc Artif Intern Organs (1972) 0.83
Coated adsorbents for direct blood perfusion: HEMA-activated carbon. Trans Am Soc Artif Intern Organs (1971) 0.83
Coated adsorbents for direct blood perfusion II. Trans Am Soc Artif Intern Organs (1972) 0.83
Venous return of an artificial heart designed to prevent right heart syndrome. Ann Biomed Eng (1974) 0.83
Hypogeusia and zinc depletion in chronic dialysis patients. Am J Clin Nutr (1978) 0.82
Long-term effects of the artificial heart. Ann Surg (1974) 0.82
The artificial kidney: a dialyser with a great area. 1944. J Am Soc Nephrol (1997) 0.82
Closed-chest left heart bypass as a treatment for myocardial infarction with shock following embolization of the left coronary artery in dogs. Arch Chir Neerl (1969) 0.82
The scintigram after renal transplantation in man. N Engl J Med (1965) 0.82
Control systems for artificial hearts. Trans Am Soc Artif Intern Organs (1968) 0.81
Artificial heart with hemispherical ventricles II and disseminated intravascular coagulation. Trans Am Soc Artif Intern Organs (1971) 0.81
Effect of vasoactive intestinal peptide on myocardial contractility and coronary blood flow in the dog: comparison with isoproterenol and forskolin. J Cardiovasc Pharmacol (1988) 0.81
Membrane vs bubble oxygenators: a prospective study of 52 patients. Arch Surg (1979) 0.81
In vivo events in the generation of pBR322. Nucleic Acids Res (1986) 0.81
Malignant carcinoid tumor with myocardial metastases. Am J Med (1999) 0.80
Clot formation inside the artificial heart device. J Thorac Cardiovasc Surg (1967) 0.80
The use of kidneys from cadavers for renal homografts in man. Trans Am Soc Artif Intern Organs (1964) 0.80
Response of the human body to the first permanent implant of the Jarvik-7 Total Artificial Heart. Trans Am Soc Artif Intern Organs (1983) 0.80
Thrombus generation within the artificial heart. J Thorac Cardiovasc Surg (1975) 0.80
Consumptive coagulopathy, shock, and the artificial heart. Trans Am Soc Artif Intern Organs (1970) 0.80
Comparison of pneumatic and electrically powered total artificial hearts in vivo. Trans Am Soc Artif Intern Organs (1978) 0.80
Stage II problems in the project of the artificial heart. J Thorac Cardiovasc Surg (1973) 0.80
Strategies to cope with negative social identity: predictions by social identity theory and relative deprivation theory. J Pers Soc Psychol (1999) 0.80
The effects of transarterial left ventricular bypass on hemodynamics of the failing left ventricle in sheep. Ann Surg (1973) 0.79
Effects of partial and complete unloading of the failing left ventricle by transarterial left heart bypass. J Thorac Cardiovasc Surg (1972) 0.79
Artificial kidney and artificial heart: further considerations. Int J Artif Organs (1990) 0.79
Release of vasoactive intestinal peptide and neuropeptide Y from canine heart. Am J Physiol (1993) 0.79
Use of artificial heart for basic cardiovascular research. Chest (1975) 0.79
Comparative effect of counterpulsation and bypass on left ventricular myocardial oxygen consumption and dynamics before and after coronary occlusion. Am Heart J (1979) 0.79